The NADPARK study: A randomized phase I trial of nicotinamide riboside supplementation in Parkinson’s disease

Brage Brakedal, Christian Dölle, Frank Riemer, Yilong Ma, Gonzalo S. Nido, Geir Skeie, Alexander R. Craven, Thomas Schwarzlmüller, Njål Brekke, Joseph Diab,

Cell Metabolism · 2022 · 302 citations · 52 references

DOIFull text

Open access

Concepts

References

52